Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cooper Veterinary Products (Proprietary) Limited is a South African subsidiary of MSD Animal Health, a division of Merck & Co. The company is a prominent provider of animal health solutions, particularly known for its extensive range of ectoparasiticides marketed under the "Coopers" brand. Its product portfolio includes well-recognized treatments such as Supadip, Triatix, and Cooperzon, which are essential for controlling ticks, lice, and mites in livestock like cattle and sheep. Operating out of Spartan, South Africa, the company serves the agricultural and veterinary sectors across the region. As an integral part of the MSD global network, it focuses on enhancing animal productivity and welfare through high-quality pharmaceutical formulations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cooper Veterinary Products.